Name | N-(1-adamantyl)-N'-cyclohexylmorpholine-4-carboximidamide,hydrochloride |
---|---|
Synonyms | 4-Morpholinecarboximidine-N-1-adamantyl-N'-cyclohexane |
Description | PNU 37883 hydrochloride (PNU 37883A) is a selective vascular ATP-sensitive potassium (Kir6, KATP) channels blocker. PNU 37883 hydrochloride has diuretic effects with specific binding in kidney and vascular smooth muscle rather than in brain or pancreatic beta cells[1][2]. |
---|---|
Related Catalog | |
In Vitro | In HEK-293 cells stably expressing Kir6.2/SUR1, Kir6.2/SUR2A, Kir6.2/SUR2B or Kir6.1/SUR2B, PNU-37883A inhibits four types of KATP channels, but to different extents. Inhibition of the putative smooth muscle KATP channel types, Kir6.2/SUR2B (IC50 of 15 μM) and Kir6.1/SUR2B (IC50 of 6 μM). PNU-37883A significantly inhibits currents generated by expressing Kir6.2Δ26 alone, with an IC50 of 5 μM, which was significantly increased to 38 μM when Kir6.2Δ26 is expressed with SUR2B[1]. PNU 37883 (0.1-10 nM) hydrochloride produces a concentration-dependent attenuation of the relaxation of agmatine (100 μM) in phenylephrine- or KCl- precontracted aortic rings. However, treatment with PNU 37883 (10 nM) hydrochloride alone does not modify the vascular tone[3]. |
References |
Boiling Point | 474.1ºC at 760mmHg |
---|---|
Molecular Formula | C21H36ClN3O |
Molecular Weight | 381.98300 |
Flash Point | 240.5ºC |
Exact Mass | 381.25500 |
PSA | 36.86000 |
LogP | 4.69650 |
Safety Phrases | 22-24/25 |
---|